Abstract
This research report is about the worldwide bioarray tools, technologies and
services market. Bioarrays are also known as DNA microarrays, protein arrays,
or biochips. These key mainstream life science research products and services
involve technologies that scientists use to detect and analyze genetic and
protein material such as DNA, RNA, proteins, antibodies, stem cells, tissues,
biomarkers and so on. This study takes into account the impact of key economic
factors influencing this industry including the severe global recession of
2008-2009, pharmaceutical industry structural changes, the potential effect of
government stimulus programs on life science research, ideas about healthcare
reform and more.
This report discusses new bioarray products reaching the market including DNA
and RNA products such as high-density arrays, tiling, copy number variation,
SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation,
microRNA, sequence-capture arrays for targeted resequencing, array-based
molecular diagnostics and related areas. The study reviews microfluidic
bioarrays such as for POC diagnostics through credit card-sized devices, for
liquid chromatography, or for drug discovery optimization. This study also
discusses commercial developments in protein bioarrays and SPR biosensors.
The study shows that bioarray product and service vendors are navigating a
challenging market. Takeda Pacific' s report discusses the major areas of this
dynamic market landscape. This report shows various views of this growing
multi-billion dollar market. The report estimates that over its five-year
forecast that the bioarray product and services market would reach a high
single-digit growth rate (CAGR). The report charts the developments of
numerous companies involved in this rapidly changing and evolving industry.
This broad study provides interesting data and includes more than 64 tables
and figures. The tables include data about technologies, companies, future
product roadmaps, and more. The report presents partnering deals and includes
several years of alliance and M&A data. The report reviews twenty-four
selected companies, with details including contact information, business and
product overviews, alliances and patents or other details. This fully
searchable PDF report helps busy readers save time. This report uses
hyperlinks to help readers jump to Table of Content items or to text-linked
Internet sites.
This must-have report would benefit people with job titles including CEO, VPs,
Director of Business Development, Research Directors, Entrepreneurs, Venture
Capitalists, Investment Planners, Research Scientists, Consultants or Industry
Analysts.
Report Statistics
- Authors: Jay K. Myers, Paula Mitchell Myers
- Number of Pages: 177 pages; can be printed
About Takeda Pacific
Consultants at Takeda Pacific developed this report. The company provides
business consulting that focuses on facilitating business development and
market research projects. The business projects may involve European, Japanese
and North American Life Science companies. Since it' s founding in late 1992,
TP has reviewed or analyzed thousands of Life Science and Technology firms for
its clients.
During the past twelve years, Takeda Pacific has produced over 70 industry
reports about emerging pharma, biotech, med-devices and technology companies
and markets. Takeda Pacific also offers follow-up consulting or custom
research consulting to assist in your business development, benchmarking, or
market assessment projects.
| 
View Cart
